The global hydrate inhibitors market analysis was valued at USD  12,772.7 million in 2021 and is projected to reach USD  21,561.8 million by 2030 at a CAGR of 6.27%. The advantages of low-dosage hydrate inhibitors (LDHI) such cost-effectiveness due to requirement of less transportation, storage, and maintenance costs; and effective during extended shut-ins and in low volumes are...